Rachel Tétaz

Islet transplantation versus insulin therapy in patients with type 1 diabetes with severe hypoglycaemia or poorly controlled glycaemia after kidney transplantation (TRIMECO): a multicentre, randomised controlled trial

Sandrine Lablanche, Marie‐Christine Vantyghem, Laurence Kessler et al. · The Lancet Diabetes & Endocrinology · 2018 · 189 citations

History Of Islet Transplantation, Islet Transplantation, Urology +9

Low incidence of SARS-CoV-2, risk factors of mortality and the course of illness in the French national cohort of dialysis patients

Cécile Couchoud, Florian Bayer, Carole Ayav et al. · Kidney International · 2020 · 150 citations · Full text

Hemodialysis, Medicine, Covid-19 Pandemic +9

Five-Year Metabolic, Functional, and Safety Results of Patients With Type 1 Diabetes Transplanted With Allogenic Islets Within the Swiss-French GRAGIL Network

Sandrine Lablanche, Sophie Borot, Anne Wojtusciszyn et al. · Diabetes Care · 2015 · 117 citations

Adherence with immunosuppressive treatment after transplantation: results from the <scp>F</scp>rench trial <scp>PREDICT</scp>

Sébastien Dharancy, Magali Giral, Rachel Tétaz et al. · Clinical Transplantation · 2012 · 65 citations

Conversion to mammalian target of rapamycin inhibitors increases risk of<i>de novo</i>donor-specific antibodies

Laure-Emmanuelle Croze, Rachel Tétaz, Matthieu Roustit et al. · Transplant International · 2014 · 52 citations